Clinical study has shown that change of chemerin levels is linked to obesity because the circulating levels of chemerin is positively correlated with high body-mass index and elevated obesity-related biomarkers [204,205,206]. This evidence concerns the gene RARRES2 and obesity due to melanocortin 4 receptor deficiency.